Exelixis (EXEL) Stock Price, Quote, News & History | Benzinga

Exelixis (EXEL) Stock Price, Quote, News & History

EXELNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$42.81

1.453.51%

At close: Feb 2, 4:00 PM EST

$42.81

N/A

After Hours: 5:44 PM EST

Q4 2025 Earnings in 7 days from now on Tue Feb 10th, after the market close

Conference call scheduled in 7 days at 17:00 PMClick to view the webcast

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$42.01

Close

$42.81

Volume / Avg.

4.15M / 2.65M

Day Range

$40.54 - $42.83

52 Wk Range

32.38 - 49.62

Market Cap

$11.52B

P/E Ratio

17.99

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

12.65%

Days to Cover

10.65

Recent Exelixis Inc News

Baker Hughes To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer

Merck and Eisai report Phase 3 results showing Welireg plus Lenvima significantly improved progression-free survival in advanced kidney cancer.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

791.02M

Investing Cash Flow (TTM)

230.00M

Financing Cash Flow (TTM)

-903.06M

Free Cash Flow (TTM)

744.27M

Capital Expenditure (TTM)

-46.75M

Net Change in Cash (TTM)

117.95M

Analyst Trends and Forecast

2

1

Oct 25

3

3

Nov 25

2

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.6

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$10.67B

PE Ratio (TTM)

17.99

PE Ratio (FWD)

13.81

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.35

PB Ratio (TTM)

5.31

Earnings Yield % (TTM)

5.56%

Earnings Yield % (FWD)

7.24%

EV / EBITDA (TTM)

12.55

Price / EBITDA (TTM)

14.41

Price / Free Cash Flow (TTM)

16.46

Book Value / Share

$8.06

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$376.30M

Debt to Equity

0.08

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$42.01

Close

$42.81

Volume / Avg.

4.15M / 2.65M

Day Range

$40.54 - $42.83

52 Wk Range

32.38 - 49.62

Market Cap

$11.52B

P/E Ratio

17.99

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

12.65%

Days to Cover

10.65

About

Sector

Health Care

Industry

Biotechnology

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

Show More

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Exelixis (EXEL) stock?

A

You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Exelixis (EXEL) competitors?

A

Other companies in Exelixis’s space includes: Avidity Biosciences Inc (NASDAQ:RNA), BeOne Medicines Ltd (NASDAQ:ONC), Exact Sciences Corp (NASDAQ:EXAS), Neurocrine Biosciences Inc (NASDAQ:NBIX) and Ionis Pharmaceuticals Inc (NASDAQ:IONS).

Q

What is the forecast, or price target, for Exelixis (EXEL) stock?

A

Exelixis has a consensus price target of $45.26.

Q

What is the current price for Exelixis (EXEL)?

A

The stock price for Exelixis (NASDAQ: EXEL) is $42.81 last updated February 2, 2026 at 5:44 PM EST.

Q

Does Exelixis (EXEL) pay a dividend?

A

There are no upcoming dividends for Exelixis.

Q

When is Exelixis (NASDAQ:EXEL) reporting earnings?

A

Exelixis does not have any upcoming earnings scheduled.

Q

Is Exelixis (EXEL) going to split?

A

There is no upcoming split for Exelixis.

Q

What sector and industry does Exelixis (EXEL) operate in?

A

Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Avidity Biosciences Inc

BeOne Medicines Ltd

Exact Sciences Corp

Neurocrine Biosciences Inc

Ionis Pharmaceuticals Inc

Roivant Sciences Ltd

United Therapeutics Corp